231 related articles for article (PubMed ID: 21622723)
1. Cancer stem cells and chemosensitivity.
Maugeri-Saccà M; Vigneri P; De Maria R
Clin Cancer Res; 2011 Aug; 17(15):4942-7. PubMed ID: 21622723
[TBL] [Abstract][Full Text] [Related]
2. Mithramycin A sensitizes therapy-resistant breast cancer stem cells toward genotoxic drug doxorubicin.
Saha S; Mukherjee S; Mazumdar M; Manna A; Khan P; Adhikary A; Kajal K; Jana D; Sa G; Mukherjee S; Sarkar DK; Das T
Transl Res; 2015 May; 165(5):558-77. PubMed ID: 25468484
[TBL] [Abstract][Full Text] [Related]
3. Cancer Stem Cells and Targeting Strategies.
Barbato L; Bocchetti M; Di Biase A; Regad T
Cells; 2019 Aug; 8(8):. PubMed ID: 31426611
[TBL] [Abstract][Full Text] [Related]
4. The cancer stem cell microenvironment and anti-cancer therapy.
Ghotra VP; Puigvert JC; Danen EH
Int J Radiat Biol; 2009 Nov; 85(11):955-62. PubMed ID: 19895272
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of tumor cell resistance to the current targeted-therapy agents.
Khamisipour G; Jadidi-Niaragh F; Jahromi AS; Zandi K; Hojjat-Farsangi M
Tumour Biol; 2016 Aug; 37(8):10021-39. PubMed ID: 27155851
[TBL] [Abstract][Full Text] [Related]
6. Chemical approaches to targeting drug resistance in cancer stem cells.
Sotiropoulou PA; Christodoulou MS; Silvani A; Herold-Mende C; Passarella D
Drug Discov Today; 2014 Oct; 19(10):1547-62. PubMed ID: 24819719
[TBL] [Abstract][Full Text] [Related]
7. Understanding the cancer stem cell phenotype: A step forward in the therapeutic management of cancer.
Wong ALA; Bellot GL; Hirpara JL; Pervaiz S
Biochem Pharmacol; 2019 Apr; 162():79-88. PubMed ID: 30689981
[TBL] [Abstract][Full Text] [Related]
8. A role for cancer stem cells in therapy resistance: cellular and molecular mechanisms.
Cojoc M; Mäbert K; Muders MH; Dubrovska A
Semin Cancer Biol; 2015 Apr; 31():16-27. PubMed ID: 24956577
[TBL] [Abstract][Full Text] [Related]
9. Cancer stem cells--important players in tumor therapy resistance.
Colak S; Medema JP
FEBS J; 2014 Nov; 281(21):4779-91. PubMed ID: 25158828
[TBL] [Abstract][Full Text] [Related]
10. Cancer stem cells in prostate cancer chemoresistance.
Ni J; Cozzi P; Hao J; Duan W; Graham P; Kearsley J; Li Y
Curr Cancer Drug Targets; 2014; 14(3):225-40. PubMed ID: 24720286
[TBL] [Abstract][Full Text] [Related]
11. Cancer stem cells and chemoresistance: The smartest survives the raid.
Zhao J
Pharmacol Ther; 2016 Apr; 160():145-58. PubMed ID: 26899500
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer chemoresistance: emerging importance of cancer stem cells.
Chuthapisith S; Eremin J; El-Sheemey M; Eremin O
Surg Oncol; 2010 Mar; 19(1):27-32. PubMed ID: 19251410
[TBL] [Abstract][Full Text] [Related]
13. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
[TBL] [Abstract][Full Text] [Related]
14. Approaches to Targeting Cancer Stem Cells in Solid Tumors.
Caldas-Lopes E; Gomez-Arteaga A; Guzman ML
Curr Stem Cell Res Ther; 2019; 14(5):421-427. PubMed ID: 30806324
[TBL] [Abstract][Full Text] [Related]
15. Expression of miR-200c in claudin-low breast cancer alters stem cell functionality, enhances chemosensitivity and reduces metastatic potential.
Knezevic J; Pfefferle AD; Petrovic I; Greene SB; Perou CM; Rosen JM
Oncogene; 2015 Dec; 34(49):5997-6006. PubMed ID: 25746005
[TBL] [Abstract][Full Text] [Related]
16. Leukaemic stem cells: drug resistance, metastasis and therapeutic implications.
Wong RS; Cheong SK
Malays J Pathol; 2012 Dec; 34(2):77-88. PubMed ID: 23424769
[TBL] [Abstract][Full Text] [Related]
17. [Mechanisms of resistance of cancer stem cells to chemotherapy].
Pascussi JM
Bull Cancer; 2017 Dec; 104(12):1080-1084. PubMed ID: 29173972
[No Abstract] [Full Text] [Related]
18. Mechanisms promoting physiological cells progression into tumorigenesis.
Korbut E; Ptak-Belowska A; Brzozowski T
J Physiol Pharmacol; 2012 Dec; 63(6):565-70. PubMed ID: 23388471
[TBL] [Abstract][Full Text] [Related]
19. The clinical and therapeutic implications of cancer stem cell biology.
Cheng L; Alexander R; Zhang S; Pan CX; MacLennan GT; Lopez-Beltran A; Montironi R
Expert Rev Anticancer Ther; 2011 Jul; 11(7):1131-43. PubMed ID: 21806335
[TBL] [Abstract][Full Text] [Related]
20. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
Shapira A; Livney YD; Broxterman HJ; Assaraf YG
Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
